Patient-Reported
Evidence Snapshot
12
Evidence relationships
13
Studies reviewed
7
Interventions evaluated
Strongest evidence area
Continuous glucose monitoring
Top Evidence Areas
| Rank | Intervention | Outcome | Effectiveness | Strength | Consistency | Studies |
|---|---|---|---|---|---|---|
| #1 | Continuous glucose monitoring | Quality of life | Neutral | Weak | Unclear | 1 |
| #2 | Continuous glucose monitoring | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| #3 | Erythropoietin (EPO) | RT2 reaction time (1 Back task) | Moderate Positive | Limited | Consistent | 1 |
| #4 | Insulin Glargine Lixisenatide dosis | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| #5 | Mobile app for gestational diabetes self Management | Maternity diabetes treatment satisfaction | Moderate Positive | Weak | Unclear | 1 |
| #6 | Needle Free injection | Injection Associated pain | Moderate Positive | Limited | Unclear | 1 |
| #7 | Needle Free injection | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| #8 | Remote Educational Program | Hypoglycemia symptom score | Moderate Positive | Limited | Unclear | 1 |
| #9 | Remote Educational Program | Quality of life | Neutral | Weak | Unclear | 2 |
| #10 | Remote Educational Program | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
Rank #1
Quality of life
Continuous glucose monitoring
Effectiveness
NeutralStrength
WeakConsistency
UnclearStudies
1
Rank #2
Treatment satisfaction
Continuous glucose monitoring
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Rank #3
RT2 reaction time (1 Back task)
Erythropoietin (EPO)
Effectiveness
Moderate PositiveStrength
LimitedConsistency
ConsistentStudies
1
Rank #4
Treatment satisfaction
Insulin Glargine Lixisenatide dosis
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Rank #5
Maternity diabetes treatment satisfaction
Mobile app for gestational diabetes self Management
Effectiveness
Moderate PositiveStrength
WeakConsistency
UnclearStudies
1
Rank #6
Injection Associated pain
Needle Free injection
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Rank #7
Treatment satisfaction
Needle Free injection
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Rank #8
Hypoglycemia symptom score
Remote Educational Program
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Rank #9
Quality of life
Remote Educational Program
Effectiveness
NeutralStrength
WeakConsistency
UnclearStudies
2
Rank #10
Treatment satisfaction
Remote Educational Program
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Practical Questions
Which interventions are most often studied for Patient-Reported?
outcomeBased on 7 evidence relationships across 8 studies
Outcomes:
Quality of lifeTreatment satisfactionInjection Associated painHypoglycemia symptom score
Interventions:
Continuous glucose monitoringNeedle Free injectionRemote Educational Program
Which interventions need more research for Patient-Reported?
evidenceBased on 3 evidence relationships across 4 studies
Outcomes:
Quality of lifeTreatment satisfaction
Interventions:
Continuous glucose monitoringRemote Educational Program
How does Continuous glucose monitoring compare with Insulin Glargine-Lixisenatide dosis for Patient-Reported?
compareVery Low Evidence
Within Patient-Reported, the table evidence for Continuous glucose monitoring and Insulin Glargine-Lixisenatide dosis is similar or too limited to clearly favor one. Interpret cautiously when study counts are low.
Continuous glucose monitoring
Evidence:46.0
Effectiveness:80.0
Studies:1
Pairs:1
limited
Insulin Glargine-Lixisenatide dosis
Evidence:44.7
Effectiveness:80.0
Studies:1
Pairs:1
limited
No clear winner based on current evidence
Limitations
Only 1 supporting study per compared itemConsistency scores not available for all compared itemsSome compared items based on single evidence pair
Comparison based on only 1 supporting study per item.
Evidence Landscape
Evidence landscape
Each bubble represents an evidence relationship. Position shows effectiveness and strength; size reflects study volume.
Limited evidence
Promising
Reliable
High impact
Lower Evidence Strength→Higher Evidence Strength
Lower Effectiveness→Higher Effectiveness
Explore by Intervention
| Intervention | Pairs | Research | Avg Strength |
|---|---|---|---|
| Remote Educational Program | 3 | 2 | 40 |
| Continuous glucose monitoring | 2 | 1 | 41 |
| Erythropoietin (EPO) | 1 | 1 | 44 |
| Insulin Glargine Lixisenatide dosis | 1 | 1 | 45 |
| Mobile app for gestational diabetes self Management | 1 | 1 | 39 |
| Needle Free injection | 2 | 1 | 44 |
| T1D education | 2 | 1 | 41 |
Latest Research
Erythropoietin may improve some cognitive tasks during low blood sugar in type 1 diabetes
Published: 16 de mayo de 2026
int-erythropoietin
out-rt2-reaction-time-1-back-task
Nepalese women with gestational diabetes find a mobile app easy to use and satisfying for self-management
Published: 16 de mayo de 2026
int-mobile-app-for-gestational-diabetes-self-management
out-maternity-diabetes-treatment-satisfaction
Hybrid diabetes education with CGM modestly improved HbA1c and well-being in adults
Published: 15 de mayo de 2026
int-remote-educational-program
out-hypoglycemia-symptom-scoreout-quality-of-life
Online school staff training improved type 1 diabetes knowledge and confidence
Published: 15 de mayo de 2026
int-t1d-education
out-diabetes-related-misconceptionsout-perceived-diabetes-management-competence
Real-time CGM significantly improves HbA1c and time in range in poorly controlled type 2 diabetes
Published: 7 de mayo de 2026
int-continuous-glucose-monitoring
out-quality-of-lifeout-treatment-satisfaction
Remote education program improves carbohydrate counting but not blood sugar control in youth with type 1 diabetes
Published: 7 de mayo de 2026
int-remote-educational-program
out-quality-of-life
Needle-free insulin injection improves blood sugar control and reduces pain in hospitalized type 2 diabetes patients
Published: 7 de mayo de 2026
int-needle-free-injection
out-injection-associated-painout-treatment-satisfaction
Switching from MDI to iGlarLixi kept HbA1c similar and lowered weight
Published: 6 de mayo de 2026
int-insulin-glargine-lixisenatide-dosis
out-treatment-satisfaction
Full Evidence Table
Showing 12 of 12 evidence pairs
Intervention | Outcome | Effectiveness | Strength | Consistency | Studies |
|---|---|---|---|---|---|
| Continuous glucose monitoring | Quality of life | Neutral | Weak | Unclear | 1 |
| Continuous glucose monitoring | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| Erythropoietin (EPO) | RT2 reaction time (1 Back task) | Moderate Positive | Limited | Consistent | 1 |
| Insulin Glargine Lixisenatide dosis | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| Mobile app for gestational diabetes self Management | Maternity diabetes treatment satisfaction | Moderate Positive | Weak | Unclear | 1 |
| Needle Free injection | Injection Associated pain | Moderate Positive | Limited | Unclear | 1 |
| Needle Free injection | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| Remote Educational Program | Hypoglycemia symptom score | Moderate Positive | Limited | Unclear | 1 |
| Remote Educational Program | Quality of life | Neutral | Weak | Unclear | 2 |
| Remote Educational Program | Treatment satisfaction | Moderate Positive | Limited | Unclear | 1 |
| T1D education | Diabetes Related misconceptions | Moderate Positive | Limited | Unclear | 1 |
| T1D education | Perceived diabetes management competence | Moderate Positive | Limited | Unclear | 1 |
Intervention → Outcome
Continuous glucose monitoring → Quality of life
Effectiveness
NeutralStrength
WeakConsistency
UnclearStudies
1
Intervention → Outcome
Continuous glucose monitoring → Treatment satisfaction
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
Erythropoietin (EPO) → RT2 reaction time (1 Back task)
Effectiveness
Moderate PositiveStrength
LimitedConsistency
ConsistentStudies
1
Intervention → Outcome
Insulin Glargine Lixisenatide dosis → Treatment satisfaction
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
Mobile app for gestational diabetes self Management → Maternity diabetes treatment satisfaction
Effectiveness
Moderate PositiveStrength
WeakConsistency
UnclearStudies
1
Intervention → Outcome
Needle Free injection → Injection Associated pain
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
Needle Free injection → Treatment satisfaction
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
Remote Educational Program → Hypoglycemia symptom score
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
Remote Educational Program → Quality of life
Effectiveness
NeutralStrength
WeakConsistency
UnclearStudies
2
Intervention → Outcome
Remote Educational Program → Treatment satisfaction
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
T1D education → Diabetes Related misconceptions
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
Intervention → Outcome
T1D education → Perceived diabetes management competence
Effectiveness
Moderate PositiveStrength
LimitedConsistency
UnclearStudies
1
